CABA vs XRAY · $143.9M cap vs rev $3.68B
Cabaletta Bio Inc (CABA) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
CABA does not have a complete income-statement cache yet.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
CABA currently screens at market cap $143.9M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the CABA and XRAY stock pages for the full models.
Not investment advice.